Dr. Lacouture is a Board-certified dermatologist with special interest in dermatologic conditions in people living with cancer. His clinical career has been focused on the recognition and management of side effects affecting the skin, hair, and nails of cancer patients and survivors. His clinical program provides pretreatment counseling and preventive efforts to minimize the development of adverse events as well as rapid attention to people who develop them. Close communication with treating oncologists ensures that interventions against untoward events do not affect the effectiveness of cancer treatments. In summary, the ultimate goal is to ensure the best dermatology-related quality of life and benefit from anticancer treatments.
Dr Lacouture’s research focuses on major components of dermatologic adverse events: the accurate description and grading of severity; the impact on quality of life; the identification of factors that place individuals at higher risk; and the development of treatments to mitigate them. A basic tenet of this research is to explore new skin treatments that do not hamper the effectiveness of anticancer drugs. A new field emerging focuses on the dermatologic effects of cancer therapies in long-term cancer survivors, the first step toward ensuring long-term skin health after cancer therapies.
As an associate attending at Memorial Sloan-Kettering Cancer Center in New York City, and director of the Onco-dermatology Program in the Dermatology Service, his clinical work focuses on dermatologic conditions in people living with cancer. His teaching role to residents, students, and visiting nurses and doctors is conducted as an Associate Professor of Dermatology at Weill Cornell Medical School. He is founding Co-chair of the Skin Toxicity Study Group of the Multinational Association of Supportive Care in Cancer, an international organization devoted to the understanding of side effects in cancer patients and has been selected as Physican of the Year by CancerCare.